Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Systemic Sclerosis (Scleroderma) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Systemic Sclerosis (Scleroderma) 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Actelion Ltd 33
Clinical Trial Overview of Actelion Ltd 33
United Therapeutics Corporation 34
Clinical Trial Overview of United Therapeutics Corporation 34
MediQuest Therapeutics, Inc. 35
Clinical Trial Overview of MediQuest Therapeutics, Inc. 35
Benesis Corporation 36
Clinical Trial Overview of Benesis Corporation 36
MedImmune, LLC 37
Clinical Trial Overview of MedImmune, LLC 37
Roche Nederland B.V. 38
Clinical Trial Overview of Roche Nederland B.V. 38
Daval International Ltd. 39
Clinical Trial Overview of Daval International Ltd. 39
Amira Pharmaceuticals, Inc. 40
Clinical Trial Overview of Amira Pharmaceuticals, Inc. 40
Italfarmaco S.p.A. 41
Clinical Trial Overview of Italfarmaco S.p.A. 41
Active Biotech AB 42
Clinical Trial Overview of Active Biotech AB 42
Novartis AG 43
Clinical Trial Overview of Novartis AG 43
Merck & Co., Inc. 44
Clinical Trial Overview of Merck & Co., Inc. 44
Allergan, Inc. 45
Clinical Trial Overview of Allergan, Inc. 45
Genzyme Corporation 46
Clinical Trial Overview of Genzyme Corporation 46
Bristol-Myers Squibb Company 47
Clinical Trial Overview of Bristol-Myers Squibb Company 47
Clinical Trial Overview of Top Universities / Institutes / Hospitals 48
Fred Hutchinson Cancer Research Center 48
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 48
The National Institute of Allergy and Infectious Diseases 49
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 49
Rouen University Hospital 50
Clinical Trial Overview of Rouen University Hospital 50
University of Michigan 51
Clinical Trial Overview of University of Michigan 51
Johns Hopkins University 52
Clinical Trial Overview of Johns Hopkins University 52
Assistance Publique - Hopitaux de Paris 53
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 53
Stanford University 54
Clinical Trial Overview of Stanford University 54
University of California, Los Angeles 55
Clinical Trial Overview of University of California, Los Angeles 55
Hospital for Special Surgery 56
Clinical Trial Overview of Hospital for Special Surgery 56
University of Medicine and Dentistry New Jersey 57
Clinical Trial Overview of University of Medicine and Dentistry New Jersey 57
Duke University 58
Clinical Trial Overview of Duke University 58
Boston University 59
Clinical Trial Overview of Boston University 59
Federal University of Sao Paulo 60
Clinical Trial Overview of Federal University of Sao Paulo 60
Charite University 61
Clinical Trial Overview of Charite University 61
Georgetown University 62
Clinical Trial Overview of Georgetown University 62
Northwestern University 63
Clinical Trial Overview of Northwestern University 63
University of Dundee 64
Clinical Trial Overview of University of Dundee 64
Ghent University Hospital 65
Clinical Trial Overview of Ghent University Hospital 65
Universita' Politecnica delle Marche 66
Clinical Trial Overview of Universita' Politecnica delle Marche 66
Alexandria University 67
Clinical Trial Overview of Alexandria University 67
Five Key Clinical Profiles 68
Appendix 91
Abbreviations 91
Definitions 91
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 95
List of Tables
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 12
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 16
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, G7 Countries, 2012* 18
Systemic Sclerosis (Scleroderma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, E7 Countries, 2012* 20
Systemic Sclerosis (Scleroderma) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2012* 33
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2012* 34
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by MediQuest Therapeutics, Inc., 2012* 35
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Benesis Corporation, 2012* 36
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2012* 37
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Roche Nederland B.V., 2012* 38
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daval International Ltd., 2012* 39
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amira Pharmaceuticals, Inc., 2012* 40
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Italfarmaco S.p.A., 2012* 41
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Active Biotech AB, 2012* 42
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 43
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 44
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2012* 45
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2012* 46
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 47
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 48
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2012* 49
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2012* 50
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2012* 51
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012* 52
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 53
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 54
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012* 55
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital for Special Surgery, 2012* 56
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012* 57
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 58
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2012* 59
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2012* 60
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2012* 61
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University, 2012* 62
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 63
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Dundee, 2012* 64
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2012* 65
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita' Politecnica delle Marche, 2012* 66
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexandria University, 2012* 67
List of Figures
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 12
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 16
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Systemic Sclerosis (Scleroderma) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Systemic Sclerosis (Scleroderma) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Systemic Sclerosis (Scleroderma) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
Systemic Sclerosis (Scleroderma) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
GlobalData Methodology 93
